Iodine × 懷孕(碘營養與胎兒神經發育)

結論:證據支持

多監管機構與臨床學會高度一致:WHO 建議孕期碘總攝取 250 µg/日、EFSA AI 200 µg、FDA RDA 220 µg、台灣 TFDA DRIs 第八版 225 µg,ACOG/ATA/AAP/Mayo/Cleveland/Harvard 均背書每日含碘 150 µg 之孕婦綜合維他命;生物機轉明確(胎兒甲狀腺發育完全依賴母體碘供應),重度缺碘→克汀症不可逆,觀察性流行病學(ALSPAC n=1040、Hynes n=228)一致顯示輕度缺碘與子代 IQ/學業成就下降有關。

B 🟡 B 初步證據 已發布 ⚠️ medium — moderate promotional content
⚠️ 標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

多監管機構與臨床學會高度一致:WHO 建議孕期碘總攝取 250 µg/日、EFSA AI 200 µg、FDA RDA 220 µg、台灣 TFDA DRIs 第八版 225 µg,ACOG/ATA/AAP/Mayo/Cleveland/Harvard 均背書每日含碘 150 µg 之孕婦綜合維他命;生物機轉明確(胎兒甲狀腺發育完全依賴母體碘供應),重度缺碘→克汀症不可逆,觀察性流行病學(ALSPAC n=1040、Hynes n=228)一致顯示輕度缺碘與子代 IQ/學業成就下降有關。

限制條件:唯一具足夠 power 的 RCT(Gowachirapant 2017,Lancet D&E,n=832)在輕度缺碘族群補充 KI 200 µg/day 後,子代 5-6 歲全量 IQ 無顯著改善(MD -1.07,p=0.34);Cochrane Harding 2017 認定認知結果「證據不足」。

整體判定:觀察性證據強、監管共識強、安全性佳、RCT 認知終點陰性但系統性限制(介入時間點過晚、輕度缺碘邊際效益窗口窄),綜合定為 A 而非 S。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.72
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 已發布
信心度
81%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧/統合分析

各層「支持此療效」的程度

分數越低=該層越不支持
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.58
L3 機轉生理合理性
0.75
L11 AI 複核獨立判讀
0.80
L2 PubMed原始文獻
0.85
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.718
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — A 級條件未達 (需 E1-E3 + L5≥2 supportive + L4 無 against;實際 E1 / L5=1 / L4_against=0)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)
PMID: 23706508 2013 Cohort n = 1,040
結論:Children of mothers with iodine/creatinine <150 mcg/g had higher odds of scores in lowest quartile for verbal IQ (OR 1.58, 95% CI 1.09-2.30; p=0.02), reading accuracy (OR 1.69, 95% CI 1.15-2.49; p=0.007), and reading comprehension (OR 1.54, 95% CI 1.06-2.23; p=0.02), after adjustment for 21 confounders. Establishes mild deficiency as a risk factor for offspring cognitive deficit in iodine-replete-by-policy population.
🟢 高品質 政府資助 效應量:[object Object]
前往 PubMed
Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9-year follow-up of the gestational iodine cohort (Hynes, Tasmania)
PMID: 23633204 2013 Cohort n = 228
結論:Children of mothers with UIC <150 mcg/L had significantly lower scores in spelling (-10%, p=0.03), grammar (-7.6%, p=0.04), and English-literacy (-5.6%, p=0.04) at age 9 vs adequate-iodine mothers, after adjustment. Effect persisted despite resolution of iodine deficiency at population level by time of testing — suggesting in-utero deficit is not corrected by post-natal repletion.
政府資助 效應量:[object Object]
前往 PubMed
Iodine supplementation for women during the preconception, pregnancy and postpartum period
PMID: 28260263 2017 Cochrane SR n = 2,643
結論:In mild-to-moderate deficiency, iodine reduced postpartum hyperthyroidism (RR 0.68, 95% CI 0.42-1.07) and elevated TgAb (RR 0.95, low-quality), with possible reduction in infant TSH (low-quality evidence). Insufficient evidence to determine effects on infant cognitive outcomes — only 1 trial (n=131) reported neurodevelopment with no clear difference. Severe-deficiency setting trials (older, mostly iodised oil) suggested reductions in cretinism. Authors conclude evidence is insufficient to draw definitive conclusions on benefits/harms of routine supplementation in pregnancy and call for adequately powered RCTs.
🟢 高品質 學術資助 效應量:[object Object]
前往 PubMed
Effect of iodine supplementation in pregnant women on child neurodevelopment: a randomised, double-blind, placebo-controlled trial (Gowachirapant, Lancet Diabetes Endocrinol)
PMID: 29030199 2017 RCT (double-blind) n = 832
結論:Iodine supplementation did not improve child cognition at 5-6 years: adjusted mean difference in Full-Scale IQ -1.07 points (95% CI -3.30 to 1.16; p=0.34) vs placebo. Maternal urinary iodine increased as expected; thyroid function preserved. First and to date only adequately powered RCT of iodine supplementation for neurodevelopmental endpoint in mild-deficiency setting, finding no benefit of routine supplementation when initiated in first trimester.
🟢 高品質 政府資助 效應量:[object Object]
前往 PubMed
The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial
PMID: 26654905 2014 RCT (double-blind) n = 56
結論:No significant difference between iodine and placebo on any BSID-III subscale at 18 months. Trial substantially underpowered (n=56 vs original target much larger; recruitment difficulties). Findings consistent with later larger Gowachirapant 2017 RCT but limited by sample size.
🟠 品質有限 政府資助
前往 PubMed
Iodine and mental development of children 5 years old and under: a systematic review and meta-analysis (Bougma)
PMID: 23609774 2013 統合分析 n = 12,291
結論:Pooled effect of severe iodine deficiency on offspring mental development: -6.9 to -10.2 IQ points (across study designs), with greater deficits in severe than in mild deficiency. RCT subgroup of supplementation in moderate-to-severe deficiency showed gain of 8.7 IQ points (95% CI 1.85-15.59). For mild deficiency, observational data suggest 1-2 IQ-point deficits but RCT evidence is sparse. Substantial heterogeneity by baseline iodine status and design.
學術資助 效應量:[object Object]
前往 PubMed
2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children (Lazarus et al.)
PMID: 24783053 2014 Other
結論:Strong consensus recommendation that women in iodine-insufficient regions take 150 mcg/day iodine pre-conception through lactation, despite sparse RCT evidence at the time, on grounds of (i) consistent observational evidence of mild-deficiency harm, (ii) low risk of recommended dose, and (iii) plausibility from severe-deficiency RCTs. Reflects guideline-level supportive stance contemporaneous with mixed RCT evidence.
學術資助
前往 PubMed

L4a US FDA
支持
Iodized salt or iodized table salt is the article of commerce, salt for human food use, to which has been added cuprous iodide or potassium iodide. The label shall bear the statement 'This salt supplies iodide, a necessary nutrient'. Cuprous iodide and potassium iodide may be added to table salt as a source of dietary iodine in an amount not greater than 0.01 percent. 來源↗
L4b EU EFSA
支持
Iodine contributes to normal cognitive function, normal functioning of the nervous system, the maintenance of normal skin, normal production of thyroid hormones and normal thyroid function, and contributes to normal growth of children 來源↗
L4c UK NHS
謹慎
Adults need 140 micrograms (μg) of iodine a day. Most people should be able to get all the iodine they need by eating a varied and balanced diet. Taking high doses of iodine for long periods of time could change the way your thyroid gland works. This can lead to a wide range of different symptoms, such as weight gain. Taking 0.5mg or less a day of iodine supplements is unlikely to cause any harm. 來源↗
L4d TW TFDA / 衛福部
支持
孕婦碘的每日建議攝取量為225微克,較一般成人140微克高出許多;衛生福利部建議孕婦及哺乳婦使用加碘鹽,並可適量攝取含碘量豐富的食物,如海帶、海藻類等。 來源↗
L4e WHO
支持
All food-grade salt, used in household and food processing should be fortified with iodine as a safe and effective strategy for the prevention and control of iodine deficiency disorders in populations living in stable and emergency settings. 來源↗

L5a NIH Office of Dietary Supplements
支持
Iodine is a mineral found in some foods. The body needs iodine to make thyroid hormones. These hormones control the body's metabolism and many other important functions. The body also needs thyroid hormones for proper bone and brain development during pregnancy and infancy. 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
支持
If you're pregnant or breastfeeding, you should take a prenatal vitamin that contains 250 micrograms of iodine daily. Not all prenatal vitamins contain iodine, so double-check the nutrients on the bottle. 來源↗
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
中性
— 本適應症無對應資料

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 中度
📍立場總覽

PTT BabyMother 板與 Dcard 對孕期補碘討論度中等且偏理性。多數媽媽認知到台灣屬缺碘地區、進口鹽多為無碘鹽,故強調備孕/孕期改用碘鹽,並透過含碘孕婦綜合維他命(新寶納多、Elevit、活力媽媽)補足。少數有甲亢/甲狀腺問題者被醫師要求限碘,引發海帶等高碘食物該不該多吃的辯論。

💬社群實感

多數正面(多以缺碘風險與胎兒腦部發育為由,認同孕期改用碘鹽或選含碘孕婦維他命;屬預防性共識而非自覺療效)

破解迷思 社群最常見的 4 個誤解
事實「台灣四面環海所以不缺碘」(錯誤,台灣其實屬缺碘地區,且進口鹽多為無碘鹽)
事實「多吃海帶、紫菜就能補足碘」(不可靠,台灣海帶碘含量不穩定且非天天食用,仍應以碘鹽為主)
事實「大脖子都要多吃海帶」(部分大脖子為甲亢,反而應限碘)
事實「碘多多益善」(過量碘亦可能誘發甲狀腺腫大或甲狀腺疾病)
🩹 社群通報的副作用
  • 甲狀腺機能亢進(甲亢)孕婦補碘後病情顧慮,需醫師限碘
  • 含碘綜合維他命常伴隨鐵劑導致的反胃、便祕(多歸因於鐵而非碘本身)
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • 善存新寶納多 (Centrum Prenatal)
  • 澳洲 Elevit(愛樂維,多為海外代購)
  • 活力媽媽 (Yannigo)
  • 台鹽碘鹽(碘酸鉀/碘化鉀加碘鹽)

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

台鹽健康加碘鹽 1kg NT$35(碘 20-33 mg/kg)

代表來源 ↗
L10b · TFDA 法定身份 官方認定

碘為必需營養素。本產品加碘。但甲狀腺病人應諮詢相關醫師意見。

來源 ↗

  • 常規產前照護(早期且定期產檢)
  • 孕前及孕早期補充葉酸(每日至少 400 微克)
  • 健康生活型態(戒菸戒酒、均衡飲食、適度運動)
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 7 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v35 engine_version: v1.0 claim_id: CLM-COND-pregnancy-INT-iodine-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-pregnancy-INT-iodine-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "碘能改善懷孕(碘營養與胎兒神經發育)",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 3,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟡 B 初步證據"
  }
}